High‐Sensitivity LC‐MS/MS Approach for Accurate Quantification of N ‐Nitroso Duloxetine in Duloxetine Pharmaceutical Formulations
Biomedical Chromatography · 2025-06 · 39 (6)
DOI: 10.1002/bmc.70101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 05.05.2025. Verfasst von Syam Sundhar Sai Kumar Boppana und 4 weiteren Autor:innen. Beteiligte Einrichtung: Vibrant Life Sciences Pvt Ltd., Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Duloxetine Hydrochloride, Tandem Mass Spectrometry, Nitroso Compounds. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
The high‐sensitivity analytical method for the detection of N ‐nitroso duloxetine, which can be carcinogenic in duloxetine medication products, was successfully developed by applying liquid chromatography–tandem mass spectrometry. Chromatographic separation was achieved by using liquid chromatography–mass spectrometry was carried out by employing an Agilent Zorbax Eclipse Plus C18, 4.6 × 150 mm, 5‐μm column. The gradient elution mode was used to operate the mobile phase, which consisted of Phase A, which was a solution of 0.1% ammonia and 0.1% formic acid in water, and Phase B, 100% methanol. This approach overcame duloxetine challenges. Tandem mass spectrometric detection with positive electro spray ionization in MRM mode then found N ‐nitroso duloxetine. Quality control involves verifying the method for precision, specificity, linearity, accuracy, and robustness, following ICH and USP criteria to ensure suitability and consistent results. On the other hand, the correlation coefficient ( r ) was more than 1.000, the mean impurity recovery ranged from 100.5% to 102.4%, and the relative standard deviation (RSD) values ( n = 6) ranged from 1.54% to 2.6% over the ranges of LOQ—150%. This work seeks to simplify risk assessment for N ‐nitroso duloxetine in duloxetine pharmaceutical formulations by providing a fast and reliable quantitative LC‐MS/MS analytical method.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vibrant Life Sciences Pvt Ltd., Hyderabad, Telangana, India.
- Department of Chemistry, Vignan's Foundation for Science Technology & Research, Guntur, Andhra Pradesh, India.
- CIS Pharma, APIIC Industrial Park, Nellore District, Andhra Pradesh, India.
ORCID-Profile: Syam Sundhar Sai Kumar Boppana, Kiran Kumar Chagarlamudi, Rajesh Damarapurapu, Venkata Siva Suryanarayana Gurram, Vinod Kumar Manglige
Zitieren
APA
Boppana, S. S. S. K., Chagarlamudi, K. K., Damarapurapu, R., Gurram, V. S. S., & Manglige, V. K. (2025). High‐Sensitivity LC‐MS/MS Approach for Accurate Quantification of N ‐Nitroso Duloxetine in Duloxetine Pharmaceutical Formulations. Biomedical Chromatography, 39(6). https://doi.org/10.1002/bmc.70101
Vancouver
Boppana SSSK, Chagarlamudi KK, Damarapurapu R, Gurram VSS, Manglige VK. High‐Sensitivity LC‐MS/MS Approach for Accurate Quantification of N ‐Nitroso Duloxetine in Duloxetine Pharmaceutical Formulations. Biomedical Chromatography. 2025;39(6). doi:10.1002/bmc.70101
BibTeX
@article{Boppana2025,
author = {Boppana, Syam Sundhar Sai Kumar and Chagarlamudi, Kiran Kumar and Damarapurapu, Rajesh and Gurram, Venkata Siva Suryanarayana and Manglige, Vinod Kumar},
title = {High‐Sensitivity LC‐MS/MS Approach for Accurate Quantification of N ‐Nitroso Duloxetine in Duloxetine Pharmaceutical Formulations},
journal = {Biomedical Chromatography},
year = {2025},
volume = {39},
number = {6},
doi = {10.1002/bmc.70101}
}
EUVIMED